Clinical Trial Update: Refractory Status Epilepticus Treatment Study [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating a treatment for refractory status epilepticus (grand mal and non-convulsive forms) has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nonconvulsive Status Epilepticus
• Status Epilepticus

Snippet

Sponsor: Hospital Universitari de Bellvitge | Conditions: Grand Mal Status Epilepticus, Non-convulsive Status Epilepticus | Phase 3 | Status: COMPLETED